U.S. Centers for Disease Control and Prevention
Findings advance knowledge in cancer screening research
Published in Telemedicine Law Weekly, August 27th, 2005
Study 1: Age and race/ethnicity are predictors of whether women will receive appropriate follow-up of abnormal cervical cancer screening results, report U.S. Centers for Disease Control and Prevention (CDC) researchers.
V.B. Benard and colleagues conducted a study "to determine whether women in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) who had findings on a Papanicolaou (Pap) test of atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesions (LSIL) were followed up in accordance with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Law Weekly
More Articles from Telemedicine Law Weekly
- Hospital des Enfants, Toulouse
3D ECG enables measurement of aortic root in Marfan syndrome - Nutrition, Exercise & Weight Loss Program
Antecolic Roux limb orientation affects hernia incidence after bypass - Royal Philips Electronics
Ambient Experience radiology suite opens at Illinois children's hospital - Siemens Medical Solutions
$1.5 million pledged to Runyon foundation accelerate clinical cancer research - Aarhus University
Extraoral radiographs often over-prescribed - Aeris Therapeutics, Inc.
U.S. FDA grants fast track designation for emphysema therapy - More from this issue of Telemedicine Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
